Michael B Chancellor Selected Research

Urologic Diseases (Urinary Tract Disease)

1/2016	Use of Botulinum Toxin in Urologic Diseases.
4/2011	Promise of Urinary Nerve Growth Factor for Assessment of Overactive Bladder Syndrome.
9/2010	Urinary Nerve Growth Factor Levels in Urinary Tract Diseases With or Without Frequency Urgency Symptoms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael B Chancellor Research Topics

Disease

52	Overactive Urinary Bladder (Overactive Bladder) 01/2021 - 03/2002
27	Interstitial Cystitis (Interstitial Cystitis, Chronic) 12/2020 - 05/2002
25	Stress Urinary Incontinence 02/2013 - 01/2003
24	Cystitis 01/2022 - 05/2002
22	Pain (Aches) 09/2019 - 01/2002
19	Spinal Cord Injuries (Spinal Cord Injury) 01/2021 - 01/2002
19	Urinary Incontinence 01/2021 - 01/2002
13	Inflammation (Inflammations) 01/2022 - 04/2007
13	Lower Urinary Tract Symptoms 01/2017 - 07/2006
10	Underactive Urinary Bladder 04/2019 - 11/2008
10	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2015 - 06/2004
9	Sneezing 09/2015 - 08/2003
8	Neurogenic Urinary Bladder (Bladder, Neurogenic) 02/2016 - 01/2003
8	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2010 - 10/2004
8	Abnormal Reflex (Hyperreflexia) 10/2007 - 01/2002
7	Hemorrhagic Cystitis 01/2021 - 04/2013
6	Urinary Retention 07/2021 - 10/2004
6	Neoplasms (Cancer) 01/2021 - 05/2005
6	Prostatitis 09/2019 - 12/2006
6	Ataxia (Dyssynergia) 06/2013 - 01/2004
5	Multiple Sclerosis 01/2021 - 01/2003
5	Hematuria 01/2020 - 01/2014
5	Parkinson Disease (Parkinson's Disease) 05/2016 - 08/2003
5	Urinary Tract Infections (Urinary Tract Infection) 11/2015 - 03/2004
4	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 06/2002
4	Hypersensitivity (Allergy) 09/2019 - 07/2009
4	Urinary Bladder Neoplasms (Bladder Cancer) 03/2016 - 08/2009
4	Urge Urinary Incontinence (Urge Incontinence) 12/2015 - 01/2006
4	Nocturia 07/2014 - 07/2004
3	Disease Progression 02/2016 - 10/2009
3	Pelvic Pain 01/2016 - 03/2004
3	Urologic Diseases (Urinary Tract Disease) 01/2016 - 09/2010
3	Hypertension (High Blood Pressure) 07/2014 - 04/2012
3	Stroke (Strokes) 07/2014 - 10/2009
3	Urinary Bladder Diseases (Bladder Diseases) 08/2009 - 12/2006
2	Pelvic Neoplasms 01/2021 - 01/2020
2	COVID-19 12/2020 - 01/2020
2	Fibrosis (Cirrhosis) 01/2020 - 01/2020
2	Hyperalgesia 09/2019 - 05/2009
2	Infections 12/2016 - 03/2004
2	Obesity 07/2013 - 04/2010

Drug/Important Bio-Agent (IBA)

23	Type A Botulinum Toxins (Botox)FDA Link 01/2021 - 10/2004
18	Nerve Growth Factor (NGF)IBA 01/2017 - 09/2002
18	Pharmaceutical PreparationsIBA 03/2016 - 01/2002
15	Botulinum Toxins (Botulinum Toxin)IBA 01/2021 - 01/2002
12	Cholinergic Antagonists (Anticholinergics)IBA 01/2021 - 01/2003
12	Capsaicin (Zostrix)FDA Link 09/2019 - 01/2002
11	Muscarinic AntagonistsIBA 01/2019 - 02/2005
11	Biomarkers (Surrogate Marker)IBA 10/2018 - 11/2008
8	Liposomes (Liposome)IBA 01/2017 - 12/2006
7	salicylhydroxamic acid (SHAM)IBA 01/2017 - 09/2005
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2014 - 02/2006
7	incobotulinumtoxinA FDA Link 06/2014 - 07/2003
6	Tacrolimus (Prograf)FDA LinkGeneric 03/2016 - 03/2011
6	ProstaglandinsIBA 01/2014 - 02/2006
5	CytokinesIBA 12/2020 - 02/2006
5	Therapeutic UsesIBA 09/2019 - 06/2004
5	Messenger RNA (mRNA)IBA 01/2017 - 03/2008
4	Proteins (Proteins, Gene)FDA Link 11/2020 - 03/2008
4	Duloxetine Hydrochloride (Cymbalta)FDA Link 09/2015 - 01/2005
4	C-Reactive ProteinIBA 07/2014 - 04/2012
3	Cholinergic Agents (Cholinergics)IBA 01/2021 - 03/2008
3	resiniferatoxinIBA 01/2017 - 01/2003
3	Acetic Acid (Vinegar)FDA LinkGeneric 01/2016 - 09/2002
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2015 - 02/2007
3	Urethane (Ethyl Carbamate)IBA 09/2015 - 08/2003
3	Dinoprostone (PGE2)FDA Link 01/2014 - 12/2010
3	Neurotransmitter Agents (Neurotransmitter)IBA 10/2013 - 02/2002
3	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 09/2013 - 02/2005
3	Adrenergic Receptors (Adrenergic Receptor)IBA 03/2009 - 02/2007
3	Tolterodine Tartrate (Detrol)FDA Link 10/2008 - 10/2004
3	Estrogens (Estrogen)FDA Link 01/2006 - 01/2002
2	Cadherins (E-Cadherin)IBA 01/2021 - 10/2016
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2021 - 04/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 10/2018
2	RNA (Ribonucleic Acid)IBA 01/2020 - 12/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2018 - 01/2016
2	Antisense OligonucleotidesIBA 01/2017 - 01/2016
2	ZM 241385 (ZM241385)IBA 05/2016 - 05/2012
2	Formaldehyde (Formol)FDA Link 10/2015 - 01/2014
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 09/2015 - 10/2009
2	Hemoglobins (Hemoglobin)IBA 07/2014 - 04/2012
2	Serum AlbuminIBA 07/2014 - 07/2012
2	Streptozocin (Streptozotocin)FDA Link 01/2014 - 09/2002
2	AndrogensIBA 10/2013 - 07/2013
2	Testosterone (Sustanon)FDA Link 07/2013 - 07/2012

Therapy/Procedure

52	Therapeutics 07/2021 - 01/2002
9	Drug Therapy (Chemotherapy) 01/2016 - 03/2002
7	Radiotherapy 01/2021 - 01/2014
7	Intravesical Administration 01/2017 - 02/2005
6	Catheters 07/2021 - 08/2003
5	Injections 06/2013 - 01/2005
4	Extracorporeal Shockwave Therapy 01/2022 - 01/2018
4	Aftercare (After-Treatment) 12/2017 - 06/2009
4	Suburethral Slings (Tension-Free Vaginal Tape) 10/2007 - 01/2003
2	Intravenous Administration 05/2016 - 05/2012
2	Cystectomy 10/2015 - 01/2014
2	Anesthesia 09/2015 - 12/2006
2	Conservative Treatment 09/2014 - 02/2013
2	Urinary Diversion (Ileal Conduit) 01/2014 - 05/2005